HIV Netherlands Australia Thailand Research Collaboration

Institution (Facility)

Homepage ROR

Also Known As

HIV Netherlands Australia Thailand Research Collaboration · Acronym: HIV-NAT

1.4K

Publications

96.9K

Citations

138

Authors

324

Concepts

About

HIV Netherlands Australia Thailand Research Collaboration is a facility institution in Bangkok, Thailand known for medicine, hiv, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	40	389	19.1K
2	Health Sciences	10	36	731
3	Engineering	3	3	92
4	Business	2	3	165
5	Management	1	2	52

HIV Netherlands Australia Thailand Research Collaboration

1.4K

Publications

96.9K

Citations

Page 1

	Year	Citations
Standards of Care for the Health of Transgender and Gender Diverse People, Version 8 Eli Coleman, Asa Radix, Walter Pierre Bouman, International Journal of Transgender Health	2022	2.2K
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection Netanya G. Sandler, Handan Wand, Annelys Roque, The Journal of Infectious Diseases	2011	1.1K
Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial Nathan Shaffer, Rutt Chuachoowong, Philip A. Mock, The Lancet ContraceptionHiv/aids CounsellingShort-course ZidovudineTreatment And PreventionPerinatal Hiv-1 Transmission	1999	798
Cabotegravir for HIV Prevention in Cisgender Men and Transgender Women Raphael J. Landovitz, Deborah Donnell, Meredith E. Clement, New England Journal of Medicine	2021	773
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study Frank van Leth, Praphan Phanuphak, Kiat Ruxrungtham, The Lancet Treatment And PreventionMedicineFirst-line Antiretroviral TherapyClinical TrialsAntiviral Drug Development	2004	683
Catastrophic payments for health care in Asia Eddy van Doorslaer, Owen O’Donnell, Ravindra P. Rannan‐Eliya, Health Economics	2007	620
Central Nervous System Viral Invasion and Inflammation During Acute HIV Infection Victor Valcour, Thep Chalermchai, Napapon Sailasuta, The Journal of Infectious Diseases	2012	521
Rilpivirine versus efavirenz with two background nucleoside or nucleotide reverse transcriptase inhibitors in treatment-naive adults infected with HIV-1 (THRIVE): a phase 3, randomised, non-inferiority trial Calvin Cohen, Jaime Andrade‐Villanueva, Bonaventura Clotet, The Lancet Treatment And PreventionMedicineHuman RetrovirusClinical TrialsRilpivirine Versus Efavirenz	2011	369
Quantitative Detection of Increasing HIV Type 1 Antibodies after Seroconversion: A Simple Assay for Detecting Recent HIV Infection and Estimating Incidence Bharat Parekh, Melanie S. Kennedy, Trudy Dobbs, AIDS Research and Human Retroviruses ImmunologyPathologyImmunotherapySimple AssayHuman Retrovirus	2002	357
Efficacy and safety of darunavir-ritonavir compared with that of lopinavir-ritonavir at 48 weeks in treatment-experienced, HIV-infected patients in TITAN: a randomised controlled phase III trial José Valdez Madruga, Daniel Berger, Marilyn McMurchie, The Lancet Treatment And PreventionAntiviral Drug DevelopmentAntiviral TherapyVirologyAntiviral Drug	2007	330

Page 1